Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Washington University School of Medicine
Arvinas Inc.
ALX Oncology Inc.
University of Colorado, Denver
University of Nebraska
Var2 Pharmaceuticals
Washington University School of Medicine
Travera Inc
A2 Biotherapeutics Inc.
Centre for Research and Technology Hellas
Turning Point Therapeutics, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
Columbia University
Vyriad, Inc.
European Organisation for Research and Treatment of Cancer - EORTC